REQUEST A DEMO
Total
USD $0.00
Search more companies

Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock Profile Updated: February 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) is an enterprise in Iran, with the main office in Tehran. The company operates in the Pharmaceutical Preparation Manufacturing industry. Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) was incorporated on April 11, 1997. Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) currently employs 596 (2025) people. From the latest financial highlights, Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) reported a net sales revenue increase of 43.53% in Q3C2026. There was a total growth of 6.88% in Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company)’s total assets over the same period. The enterprise’s net profit margin increased by 0.16% in 2026.

Legal Address
28Km Of Karaj Special Road, In Front Of The Metro Atmosphere Station
Tehran; Tehran; Postal Code: 3164816478

Contact Details: Purchase the Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) report to view the information.

Website: http://www.temad.com

Basic Information
Total Employees:
Purchase the Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) report to view the information.
Outstanding Shares:
Purchase the Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) report to view the information.
Financial Auditors:
Purchase the Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) report to view the information.
Incorporation Date:
April 11, 1997
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
76%
Purchase this report to view the information.
31.58%
Purchase this report to view the information.
3.6%
Purchase this report to view the information.
2.3%
Purchase this report to view the information.
1.3%
Company Performance
Financial values in the chart are available after Tolid Mavade Avallieh Daroupakhsh Company Public Joint Stock (Pharmaceutical Raw Materials Mgf. Company Public Shareholding Company) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
43.53%
Total Operating Revenue
43.51%
Operating Profit
72.31%
EBITDA
70.63%
Net Profit/Loss for the Period
44.19%
Total Assets
6.88%
Total Equity
-27.84%
Operating Profit Margin
7.36%
Net Profit Margin
0.16%
Return on Equity (ROE)
34%
Debt / Equity
13.8%
Quick Ratio
0.1%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?